APO Research
Talk to an analyst

APO RESEARCH · REPORT

Omics Analysis Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Omics Analysis Software Market Analysis and Forecast 2026-2032

16 April 2026256 pages

Choose your research edition.

Industry ResearchOmics Analysis Software Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Omics Analysis Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Omics Analysis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omics Analysis Software Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Omics Analysis Software Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

The global Omics Analysis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Omics Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Omics Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Omics Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Omics Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Omics Analysis Software include AI Verse, Appen, Gretel, TagX, GTS, Labelbox, Pangeanic, Pixta AI and Sapien, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Omics Analysis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Omics Analysis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Omics Analysis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Omics Analysis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Omics Analysis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Omics Analysis Software revenue, projected growth trends, production technology, application and end-user industry.

Omics Analysis Software Segment by Company

AI Verse

Appen

Gretel

TagX

GTS

Labelbox

Pangeanic

Pixta AI

Sapien

Scale AI

Shaip

SuperAnnotate

Soundsnap

Omics Analysis Software Segment by Type

Genomics Analysis Software

Transcriptomics Analysis Software

Proteomics Analysis Software

Metabolomics Analysis Software

Environmental Toxicology Analysis Software

Epigenomics Analysis Software

Others

Omics Analysis Software Segment by Application

Scientific Research

Clinical Diagnostics and Precision Medicine

Agriculture and Biotechnology

Drug Discovery

Others

Omics Analysis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omics Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omics Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omics Analysis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Omics Analysis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Omics Analysis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Omics Analysis Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Omics Analysis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Genomics Analysis Software Major Player Table 3. Transcriptomics Analysis Software Major Player Table 4. Proteomics Analysis Software Major Player Table 5. Metabolomics Analysis Software Major Player Table 6. Environmental Toxicology Analysis Software Major Player Table 7. Epigenomics Analysis Software Major Player Table 8. Others Major Player Table 9. Global Omics Analysis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Scientific Research Major Player Table 11. Clinical Diagnostics and Precision Medicine Major Player Table 12. Agriculture and Biotechnology Major Player Table 13. Drug Discovery Major Player Table 14. Others Major Player Table 15. Omics Analysis Software Industry Trends Table 16. Omics Analysis Software Industry Drivers Table 17. Omics Analysis Software Industry Opportunities and Challenges Table 18. Omics Analysis Software Industry Restraints Table 19. Global Omics Analysis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global Omics Analysis Software Market Size by Region (2021-2026) & (US$ Million) Table 21. Global Omics Analysis Software Market Share by Region (2021-2026) Table 22. Global Omics Analysis Software Market Size by Region (2027-2032) & (US$ Million) Table 23. Global Omics Analysis Software Market Share by Region (2027-2032) Table 24. Global Omics Analysis Software Revenue by Players (US$ Million) & (2021-2026) Table 25. Global Omics Analysis Software Revenue Market Share by Players (2021-2026) Table 26. Global Omics Analysis Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global Omics Analysis Software Key Players Headquarters & Area Served Table 28. Global Omics Analysis Software Players, Product Type & Application Table 29. Global Omics Analysis Software Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global Omics Analysis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Omics Analysis Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Omics Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Omics Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Omics Analysis Software Revenue Market Share by Type (2021-2026) Table 36. Global Omics Analysis Software Revenue Market Share by Type (2027-2032) Table 37. Global Omics Analysis Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Omics Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 39. Global Omics Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 40. Global Omics Analysis Software Revenue Market Share by Application (2021-2026) Table 41. Global Omics Analysis Software Revenue Market Share by Application (2027-2032) Table 42. AI Verse Company Information Table 43. AI Verse Business Overview Table 44. AI Verse Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. AI Verse Omics Analysis Software Product Portfolio Table 46. AI Verse Recent Development Table 47. Appen Company Information Table 48. Appen Business Overview Table 49. Appen Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Appen Omics Analysis Software Product Portfolio Table 51. Appen Recent Development Table 52. Gretel Company Information Table 53. Gretel Business Overview Table 54. Gretel Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Gretel Omics Analysis Software Product Portfolio Table 56. Gretel Recent Development Table 57. TagX Company Information Table 58. TagX Business Overview Table 59. TagX Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. TagX Omics Analysis Software Product Portfolio Table 61. TagX Recent Development Table 62. GTS Company Information Table 63. GTS Business Overview Table 64. GTS Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. GTS Omics Analysis Software Product Portfolio Table 66. GTS Recent Development Table 67. Labelbox Company Information Table 68. Labelbox Business Overview Table 69. Labelbox Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Labelbox Omics Analysis Software Product Portfolio Table 71. Labelbox Recent Development Table 72. Pangeanic Company Information Table 73. Pangeanic Business Overview Table 74. Pangeanic Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Pangeanic Omics Analysis Software Product Portfolio Table 76. Pangeanic Recent Development Table 77. Pixta AI Company Information Table 78. Pixta AI Business Overview Table 79. Pixta AI Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Pixta AI Omics Analysis Software Product Portfolio Table 81. Pixta AI Recent Development Table 82. Sapien Company Information Table 83. Sapien Business Overview Table 84. Sapien Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Sapien Omics Analysis Software Product Portfolio Table 86. Sapien Recent Development Table 87. Scale AI Company Information Table 88. Scale AI Business Overview Table 89. Scale AI Omics Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Scale AI Omics Analysis Software Product Portfolio Table 91. Scale AI Recent Development Table 92. Shaip Company Information Table 93. Shaip Business Overview Table 94. Shaip Omics Analysis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Shaip Omics Analysis Software Product Portfolio Table 96. Shaip Recent Development Table 97. SuperAnnotate Company Information Table 98. SuperAnnotate Business Overview Table 99. SuperAnnotate Omics Analysis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. SuperAnnotate Omics Analysis Software Product Portfolio Table 101. SuperAnnotate Recent Development Table 102. Soundsnap Company Information Table 103. Soundsnap Business Overview Table 104. Soundsnap Omics Analysis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Soundsnap Omics Analysis Software Product Portfolio Table 106. Soundsnap Recent Development Table 107. North America Omics Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Omics Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Omics Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Omics Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Omics Analysis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Omics Analysis Software Revenue by Country (2021-2026) & (US$ Million) Table 113. North America Omics Analysis Software Revenue by Country (US$ Million) & (2027-2032) Table 114. Europe Omics Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Omics Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Omics Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Omics Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Omics Analysis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Omics Analysis Software Revenue by Country (2021-2026) & (US$ Million) Table 120. Europe Omics Analysis Software Revenue by Country (US$ Million) & (2027-2032) Table 121. China Omics Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 122. China Omics Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 123. China Omics Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 124. China Omics Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Omics Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Omics Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Omics Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia Omics Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Omics Analysis Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Omics Analysis Software Revenue by Region (US$ Million) & (2021-2026) Table 131. Asia Omics Analysis Software Revenue by Region (US$ Million) & (2027-2032) Table 132. SAMEA Omics Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 133. SAMEA Omics Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 134. SAMEA Omics Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 135. SAMEA Omics Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 136. SAMEA Omics Analysis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. SAMEA Omics Analysis Software Revenue by Country (2021-2026) & (US$ Million) Table 138. SAMEA Omics Analysis Software Revenue by Country (US$ Million) & (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Omics Analysis Software Image Figure 2. Global Omics Analysis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omics Analysis Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Genomics Analysis Software Image Figure 5. Transcriptomics Analysis Software Image Figure 6. Proteomics Analysis Software Image Figure 7. Metabolomics Analysis Software Image Figure 8. Environmental Toxicology Analysis Software Image Figure 9. Epigenomics Analysis Software Image Figure 10. Others Image Figure 11. Global Omics Analysis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Omics Analysis Software Market Size Share 2021 VS 2025 VS 2032 Figure 13. Scientific Research Image Figure 14. Clinical Diagnostics and Precision Medicine Image Figure 15. Agriculture and Biotechnology Image Figure 16. Drug Discovery Image Figure 17. Others Image Figure 18. Global Omics Analysis Software Market Size (US$ Million) & (2021-2032) Figure 19. Global Omics Analysis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Omics Analysis Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Omics Analysis Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Omics Analysis Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Omics Analysis Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Omics Analysis Software Revenue Market Share by Type (2021-2032) Figure 26. Global Omics Analysis Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Omics Analysis Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global Omics Analysis Software Revenue Market Share by Application (2021-2032) Figure 29. North America Omics Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Omics Analysis Software Revenue Share by Type (2021-2032) Figure 31. North America Omics Analysis Software Revenue Share by Application (2021-2032) Figure 32. North America Omics Analysis Software Revenue Share by Country (2021-2032) Figure 33. United States Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe Omics Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Omics Analysis Software Revenue Share by Type (2021-2032) Figure 38. Europe Omics Analysis Software Revenue Share by Application (2021-2032) Figure 39. Europe Omics Analysis Software Revenue Share by Country (2021-2032) Figure 40. Germany Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China Omics Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China Omics Analysis Software Revenue Share by Type (2021-2032) Figure 50. China Omics Analysis Software Revenue Share by Application (2021-2032) Figure 51. Asia Omics Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia Omics Analysis Software Revenue Share by Type (2021-2032) Figure 53. Asia Omics Analysis Software Revenue Share by Application (2021-2032) Figure 54. Asia Omics Analysis Software Revenue Share by Region (2021-2032) Figure 55. Japan Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA Omics Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA Omics Analysis Software Revenue Share by Type (2021-2032) Figure 63. SAMEA Omics Analysis Software Revenue Share by Application (2021-2032) Figure 64. SAMEA Omics Analysis Software Revenue Share by Country (2021-2032) Figure 65. Brazil Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt Omics Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Genomics Analysis Software
  • Transcriptomics Analysis Software
  • Proteomics Analysis Software
  • Metabolomics Analysis Software
  • Environmental Toxicology Analysis Software
  • Epigenomics Analysis Software
  • Others
Applications
  • Scientific Research
  • Clinical Diagnostics and Precision Medicine
  • Agriculture and Biotechnology
  • Drug Discovery
  • Others
Companies covered
  • AI Verse
  • Appen
  • Gretel
  • TagX
  • GTS
  • Labelbox
  • Pangeanic
  • Pixta AI
  • Sapien
  • Scale AI
  • Shaip
  • SuperAnnotate
  • Soundsnap

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Omics Analysis Software Market by Type
  3. 1.2.1 Global Omics Analysis Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Genomics Analysis Software
  5. 1.2.3 Transcriptomics Analysis Software
  6. 1.2.4 Proteomics Analysis Software
  7. 1.2.5 Metabolomics Analysis Software
  8. 1.2.6 Environmental Toxicology Analysis Software
  9. 1.2.7 Epigenomics Analysis Software
  10. 1.2.8 Others
  11. 1.3 Omics Analysis Software Market by Application
  12. 1.3.1 Global Omics Analysis Software Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Scientific Research
  14. 1.3.3 Clinical Diagnostics and Precision Medicine
  15. 1.3.4 Agriculture and Biotechnology
  16. 1.3.5 Drug Discovery
  17. 1.3.6 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Omics Analysis Software Market Dynamics
  1. 2.1 Omics Analysis Software Industry Trends
  2. 2.2 Omics Analysis Software Industry Drivers
  3. 2.3 Omics Analysis Software Industry Opportunities and Challenges
  4. 2.4 Omics Analysis Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Omics Analysis Software Market Perspective (2021-2032)
  2. 3.2 Global Omics Analysis Software Growth Trends by Region
  3. 3.2.1 Global Omics Analysis Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Omics Analysis Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Omics Analysis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Omics Analysis Software Revenue by Players
  2. 4.1.1 Global Omics Analysis Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Omics Analysis Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Omics Analysis Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Omics Analysis Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Omics Analysis Software Key Players Headquarters & Area Served
  7. 4.4 Global Omics Analysis Software Players, Product Type & Application
  8. 4.5 Global Omics Analysis Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Omics Analysis Software Market CR5 and HHI
  11. 4.6.3 2025 Omics Analysis Software Tier 1, Tier 2, and Tier 3
5 Omics Analysis Software Market Size by Type
  1. 5.1 Global Omics Analysis Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Omics Analysis Software Revenue by Type (2021-2032)
  3. 5.3 Global Omics Analysis Software Revenue Market Share by Type (2021-2032)
6 Omics Analysis Software Market Size by Application
  1. 6.1 Global Omics Analysis Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Omics Analysis Software Revenue by Application (2021-2032)
  3. 6.3 Global Omics Analysis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AI Verse
  2. 7.1.1 AI Verse Company Information
  3. 7.1.2 AI Verse Business Overview
  4. 7.1.3 AI Verse Omics Analysis Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AI Verse Omics Analysis Software Product Portfolio
  6. 7.1.5 AI Verse Recent Developments
  7. 7.2 Appen
  8. 7.2.1 Appen Company Information
  9. 7.2.2 Appen Business Overview
  10. 7.2.3 Appen Omics Analysis Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Appen Omics Analysis Software Product Portfolio
  12. 7.2.5 Appen Recent Developments
  13. 7.3 Gretel
  14. 7.3.1 Gretel Company Information
  15. 7.3.2 Gretel Business Overview
  16. 7.3.3 Gretel Omics Analysis Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Gretel Omics Analysis Software Product Portfolio
  18. 7.3.5 Gretel Recent Developments
  19. 7.4 TagX
  20. 7.4.1 TagX Company Information
  21. 7.4.2 TagX Business Overview
  22. 7.4.3 TagX Omics Analysis Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 TagX Omics Analysis Software Product Portfolio
  24. 7.4.5 TagX Recent Developments
  25. 7.5 GTS
  26. 7.5.1 GTS Company Information
  27. 7.5.2 GTS Business Overview
  28. 7.5.3 GTS Omics Analysis Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GTS Omics Analysis Software Product Portfolio
  30. 7.5.5 GTS Recent Developments
  31. 7.6 Labelbox
  32. 7.6.1 Labelbox Company Information
  33. 7.6.2 Labelbox Business Overview
  34. 7.6.3 Labelbox Omics Analysis Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Labelbox Omics Analysis Software Product Portfolio
  36. 7.6.5 Labelbox Recent Developments
  37. 7.7 Pangeanic
  38. 7.7.1 Pangeanic Company Information
  39. 7.7.2 Pangeanic Business Overview
  40. 7.7.3 Pangeanic Omics Analysis Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pangeanic Omics Analysis Software Product Portfolio
  42. 7.7.5 Pangeanic Recent Developments
  43. 7.8 Pixta AI
  44. 7.8.1 Pixta AI Company Information
  45. 7.8.2 Pixta AI Business Overview
  46. 7.8.3 Pixta AI Omics Analysis Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pixta AI Omics Analysis Software Product Portfolio
  48. 7.8.5 Pixta AI Recent Developments
  49. 7.9 Sapien
  50. 7.9.1 Sapien Company Information
  51. 7.9.2 Sapien Business Overview
  52. 7.9.3 Sapien Omics Analysis Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sapien Omics Analysis Software Product Portfolio
  54. 7.9.5 Sapien Recent Developments
  55. 7.10 Scale AI
  56. 7.10.1 Scale AI Company Information
  57. 7.10.2 Scale AI Business Overview
  58. 7.10.3 Scale AI Omics Analysis Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Scale AI Omics Analysis Software Product Portfolio
  60. 7.10.5 Scale AI Recent Developments
  61. 7.11 Shaip
  62. 7.11.1 Shaip Company Information
  63. 7.11.2 Shaip Business Overview
  64. 7.11.3 Shaip Omics Analysis Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Shaip Omics Analysis Software Product Portfolio
  66. 7.11.5 Shaip Recent Developments
  67. 7.12 SuperAnnotate
  68. 7.12.1 SuperAnnotate Company Information
  69. 7.12.2 SuperAnnotate Business Overview
  70. 7.12.3 SuperAnnotate Omics Analysis Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SuperAnnotate Omics Analysis Software Product Portfolio
  72. 7.12.5 SuperAnnotate Recent Developments
  73. 7.13 Soundsnap
  74. 7.13.1 Soundsnap Company Information
  75. 7.13.2 Soundsnap Business Overview
  76. 7.13.3 Soundsnap Omics Analysis Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Soundsnap Omics Analysis Software Product Portfolio
  78. 7.13.5 Soundsnap Recent Developments
8 North America
  1. 8.1 North America Omics Analysis Software Revenue (2021-2032)
  2. 8.2 North America Omics Analysis Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Omics Analysis Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Omics Analysis Software Revenue by Type (2027-2032)
  5. 8.3 North America Omics Analysis Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Omics Analysis Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Omics Analysis Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Omics Analysis Software Revenue by Application (2027-2032)
  9. 8.5 North America Omics Analysis Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Omics Analysis Software Revenue by Country
  11. 8.6.1 North America Omics Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Omics Analysis Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Omics Analysis Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Omics Analysis Software Revenue (2021-2032)
  2. 9.2 Europe Omics Analysis Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Omics Analysis Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Omics Analysis Software Revenue by Type (2027-2032)
  5. 9.3 Europe Omics Analysis Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Omics Analysis Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Omics Analysis Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Omics Analysis Software Revenue by Application (2027-2032)
  9. 9.5 Europe Omics Analysis Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Omics Analysis Software Revenue by Country
  11. 9.6.1 Europe Omics Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Omics Analysis Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Omics Analysis Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Omics Analysis Software Revenue (2021-2032)
  2. 10.2 China Omics Analysis Software Revenue by Type (2021-2032)
  3. 10.2.1 China Omics Analysis Software Revenue by Type (2021-2026)
  4. 10.2.2 China Omics Analysis Software Revenue by Type (2027-2032)
  5. 10.3 China Omics Analysis Software Revenue Share by Type (2021-2032)
  6. 10.4 China Omics Analysis Software Revenue by Application (2021-2032)
  7. 10.4.1 China Omics Analysis Software Revenue by Application (2021-2026)
  8. 10.4.2 China Omics Analysis Software Revenue by Application (2027-2032)
  9. 10.5 China Omics Analysis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Omics Analysis Software Revenue (2021-2032)
  2. 11.2 Asia Omics Analysis Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Omics Analysis Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Omics Analysis Software Revenue by Type (2027-2032)
  5. 11.3 Asia Omics Analysis Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Omics Analysis Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Omics Analysis Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Omics Analysis Software Revenue by Application (2027-2032)
  9. 11.5 Asia Omics Analysis Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Omics Analysis Software Revenue by Country
  11. 11.6.1 Asia Omics Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Omics Analysis Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Omics Analysis Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Omics Analysis Software Revenue (2021-2032)
  2. 12.2 SAMEA Omics Analysis Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Omics Analysis Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Omics Analysis Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Omics Analysis Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Omics Analysis Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Omics Analysis Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Omics Analysis Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Omics Analysis Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Omics Analysis Software Revenue by Country
  11. 12.6.1 SAMEA Omics Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Omics Analysis Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Omics Analysis Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst